New hope for lung injury: drug may repair radiation and immunotherapy damage
NCT ID NCT07388680
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests if the drug pirfenidone can help people with lung damage caused by radiation therapy (with or without immunotherapy). About 298 adults with certain cancers who received chest radiation will take pirfenidone or a placebo for 24 weeks. The goal is to see if the drug improves lung function and helps people live longer.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMMUNE-RELATED PNEUMONIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Affiliated Hospital of Fujian Medical University, Xiehe Branch
RECRUITINGFuzhou, Fujian, China
-
Affiliated Hospital of Guangdong Medical UniversityAffiliated Hospital of Guangdong Medical University
RECRUITINGZhanjiang, Guangdong, China
-
Anhui Provincial Chest Hospital
RECRUITINGHefei, Anhui, China
-
Anyang City Cancer Hospital
RECRUITINGAnyang, Henan, China
-
Chinese Academy of Medical Sciences Cancer Hospital
RECRUITINGBeijing, Beijing Municipality, China
-
Chinese Academy of Medical Sciences Cancer Hospital Shenzhen Branch
RECRUITINGShenzhen, Guangdong, China
-
Foshan First Hospital
RECRUITINGFoshan, Guangdong, China
-
Fudan University Cancer Hospital
RECRUITINGShanghai, Shanghai Municipality, China
-
Fujian Provincial Cancer Hospital
RECRUITINGFuzhou, Fujian, China
-
Gansu Provincial Cancer Hospital
RECRUITINGGansu, Lanzhou, China
-
Gaozhou People's Hospital
RECRUITINGMaoming, Guangdong, China
-
Guangdong Provincial People's Hospital
RECRUITINGGuangzhou, Guangdong, China
-
Guangxi Medical University Cancer Hospital
RECRUITINGNanning, Guangxi, China
-
Hebei University Affiliated Hospital
RECRUITINGBaoding, Hebei, China
-
Henan Provincial Cancer Hospital
RECRUITINGZhengzhou, Henan, China
-
Hubei Provincial Cancer Hospital
RECRUITINGWuhan, Hubei, China
-
Hunan Provincial Cancer HospitalHunan Provincial Cancer Hospital
RECRUITINGChangsha, Wuhan, China
-
Jining First People's Hospital
RECRUITINGJining, Shandong, China
-
Lanzhou University First Hospital
RECRUITINGLanzhou, Gansu, China
-
Panyu Central Hospital Affiliated to Guangzhou Medical University
RECRUITINGGuangzhou, Guangdong, China
-
Shanghai Chest HospitalShanghai Chest Hospital
RECRUITINGShanghai, Shanghai Municipality, China
-
Shenzhen People's Hospital
RECRUITINGShenzhen, Guangdong, China
-
Sichuan Provincial Cancer Hospital
RECRUITINGChengdu, Sichuan, China
-
Southern Medical University - Southern Hospital
RECRUITINGGuangzhou, Guangdong, China
-
Sun Yat-sen University Cancer Center
RECRUITINGGuangzhou, Guangdong, China
-
Taizhou Cancer Hospital
RECRUITINGTaizhong, Zhejiang, China
-
The First Affiliated Hospital of Guangzhou University of Chinese Medicine
RECRUITINGGuangzhou, Guangdong, China
-
The First Affiliated Hospital of Sun Yat-sen University
RECRUITINGGuangzhou, Guangdong, China
-
The Second Affiliated Hospital of Zhejiang University School of Medicine
RECRUITINGHangzhou, Zhejiang, China
-
The Second Affiliated Hospital of Zunyi Medical University
RECRUITINGZunyi, Guizhou, China
-
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
RECRUITINGWuhan, Hubei, China
-
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
RECRUITINGWuhan, Hubei, China
-
West China Hospital of Sichuan University
RECRUITINGChengdu, Sichuan, China
-
Xuzhou Medical University Affiliated Hospital
RECRUITINGXuzhou, Jiangsu, China
-
Zhejiang Provincial Cancer HospitalZhejiang Provincial Cancer Hospital
RECRUITINGHangzhou, Zhejiang, China
-
Zhongshan People's Hospital
RECRUITINGZhongshan, Guangdong, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.